2020
DOI: 10.1021/acs.analchem.0c01288
|View full text |Cite
|
Sign up to set email alerts
|

Translational Opportunities for Microfluidic Technologies to Enable Precision Epigenomics

Abstract: Personalizing health care by taking genetic, environmental, and lifestyle factors into account is central to modern medicine. The crucial and pervasive roles epigenetic factors play in shaping gene−environment interactions are now well recognized. However, identifying robust epigenetic biomarkers and translating them to clinical tests has been difficult due in part to limitations of available platforms to detect epigenetic features genome-wide (epigenomic assays). This Feature introduces several important pros… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 99 publications
0
5
0
Order By: Relevance
“…Experimental results show that the integration of MBD beads and the vortex-type micromixer (capture rate of 72%) could significantly lower the amount of the input cfDNA sample (20 μL) while comparing to the bisulfite-based system (>1 mL) . Also, previous studies involved sophisticated manual operations that reduced the throughput and made the assay labor intensive. Although the bisulfite-based assay could be integrated on the droplet-based microfluidic system with a minimum DNA concentration of 500 pg/μL, the redundancy of sequence was still unavoidable, nor was the cfDNA extraction module integrated. On the other hand, the MBD-based assay was utilized in the microfluidic chip previously. ,, Even though the system has obtained an acceptable LOQ of 1 pg/μL, yet no epigenetic profiling module was integrated in one single system .…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Experimental results show that the integration of MBD beads and the vortex-type micromixer (capture rate of 72%) could significantly lower the amount of the input cfDNA sample (20 μL) while comparing to the bisulfite-based system (>1 mL) . Also, previous studies involved sophisticated manual operations that reduced the throughput and made the assay labor intensive. Although the bisulfite-based assay could be integrated on the droplet-based microfluidic system with a minimum DNA concentration of 500 pg/μL, the redundancy of sequence was still unavoidable, nor was the cfDNA extraction module integrated. On the other hand, the MBD-based assay was utilized in the microfluidic chip previously. ,, Even though the system has obtained an acceptable LOQ of 1 pg/μL, yet no epigenetic profiling module was integrated in one single system .…”
Section: Resultsmentioning
confidence: 99%
“…28 Also, previous studies involved sophisticated manual operations that reduced the throughput and made the assay labor intensive. 18−20 Although the bisulfite-based assay could be integrated on the droplet-based microfluidic system 33 with a minimum DNA concentration of 500 pg/μL, the redundancy of sequence was still unavoidable, nor was the cfDNA extraction module integrated. On the other hand, the MBD-based assay was utilized in the microfluidic chip previously.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Droplet-based microfluidic technologies provide a variety of solutions for high-throughput single-cell analysis 1 , 2 at the genomic 3 , epigenomic 4 , transcriptomic 5 7 , proteomic 8 , 9 and metabolomic 10 levels, with increasing applications in the fields of immunotherapies 11 , 12 , precision medicine 13 , regenerative medicine 14 , drug development 11 , 15 and diagnostics 10 , 16 . The successful translation of several such droplet-based techniques into commercial assays (e.g., ddPCR by Bio-Rad and Chromium by 10X Genomics) has led to the unprecedented adoption of microfluidic technologies in the commercial sector.…”
Section: Introductionmentioning
confidence: 99%
“…The epigenome encompasses multiple interacting regulatory elements that define phenotypic variation beyond what the DNA sequence encodes [ 1 , 2 , 3 ]. In addition to their roles in development and differentiation, epigenetic mechanisms play a fundamental role in transcriptional regulation during disease progression, further underscoring the importance of understanding their molecular bases [ 4 , 5 ].…”
Section: Introductionmentioning
confidence: 99%